pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    DNL-126
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )$DNLI Denali Therapeutics Inc.
  • Phase 2
    DPTX-3186
    Gastric Cancer Dewpoint Therapeutics Inc
  • Phase 2
    DS-01
    DS-01
    Irritable Bowel Syndrome Seed Health Inc
  • Phase 2
← prev
page 11 of 53
next →
131
Pain89
Neurology1
DS-3939
Solid Tumor
Daiichi Sankyo Co Ltd
  • Phase 2
    DS-7011
    Cutaneous Lupus Erythematosus Daiichi Sankyo Co Ltd
  • Phase 2
    DSG3-CAART
    Pemphigus Vulgaris$CABA Cabaletta Bio, Inc.
  • Phase 2
    DSP-107
    Colorectal Cancer KAHR medical Ltd
  • Phase 2
    DSP-3077
    Retinitis Pigmentosa (Retinitis) Sumitomo Pharma Co Ltd
  • Phase 2
    DT-101
    Major Depressive Disorder Draig Therapeutics Ltd
  • Phase 2
    DT-168
    Fuchs Endothelial Corneal Dystrophy (FECD)$DSGN Design Therapeutics, Inc.
  • Phase 2
    DX-126262
    Gastric Cancer Hangzhou DAC Biotech Co Ltd
  • Phase 2
    Decoy-20
    Adenoid Cystic Carcinoma (ACC)$INDP Indaptus Therapeutics, Inc.
  • Phase 2
    Dictor
    Zicthoru (diclofenac sodium)
    Chronic Low Back Pain (CLBP) Hisamitsu Pharmaceutical Co Inc
  • Phase 2
    EB-103
    B-Cell Non-Hodgkin Lymphoma$ESLA Estrella Immunopharma, Inc.
  • Phase 2
    EBT-101
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Excision BioTherapeutics Inc
  • Phase 2
    ECC-0509
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Eccogene (Shanghai) Co Ltd
  • Phase 2
    ECC-4703
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Eccogene (Shanghai) Co Ltd
  • Phase 2
    EDV-2209
    Subarachnoid Hemorrhage Edvince AB
  • Phase 2
    EEDVD-682
    Pancreatic Ductal Adenocarcinoma EnGeneIC Ltd
  • Phase 2
    EF-001
    Anaplastic Astrocytoma Everfront Biotech Inc
  • Phase 2
    EG-007
    Endometrial Cancer Shenzhen Evergreen Therapeutics Co Ltd
  • Phase 2
    EG-110A
    Neurogenic Bladder Dysfunction EG 427
  • Phase 2
    EG-501
    Cognitive Impairment Shenzhen Evergreen Therapeutics Co Ltd
  • Phase 2
    EGT-101
    Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) Esteve Pharmaceuticals SA
  • Phase 2
    EH-301
    Amyotrophic Lateral Sclerosis Elysium Health Inc
  • Phase 2
    EIS-12656
    Breast Cancer Eisbach Bio GmbH
  • Phase 2
    ELI-002 2P
    Colorectal Cancer$ELTX Elicio Therapeutics, Inc.
  • Phase 2
    ELU-42
    Diabetic Foot Ulcers Eluciderm Inc
  • Phase 2
    ELVN-002
    Human Epidermal Growth Factor Receptor 2 Positive Breast…$ELVN Enliven Therapeutics, Inc.
  • Phase 2
    EN-374
    Chronic Granulomatous Disease Ensoma Inc